Ragna Vanslembrouck

Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial

Loes van Keimpema, Frederik Nevens, Ragna Vanslembrouck et al. · Gastroenterology · 2009 · 256 citations

Urology, Polycystic Liver, Hepatology +10

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer

Katrijn Michielsen, Raphaëla C. Dresen, Ragna Vanslembrouck et al. · European Journal of Cancer · 2017 · 127 citations

Radiology, Engineering, Medical Imaging +11

Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases

Raphaëla C. Dresen, Sofie De Vuysere, Frederik De Keyzer et al. · Cancer Imaging · 2019 · 102 citations · Full text

Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation

A. J. F. Coimbra, Jordi Rimola, S. O’Byrne et al. · Alimentary Pharmacology & Therapeutics · 2015 · 71 citations · Full text

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data

Frederik Temmerman, Tom J.G. Gevers, Tsung-Yeh Ho et al. · Alimentary Pharmacology & Therapeutics · 2013 · 44 citations